AustralieFrV1, PubMed, Checkpoint, bibRecord, 003401

Medical history, lifestyle, and occupational risk factors for hairy cell leukemia: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.

Identifieur interne : 003401 ( PubMed/Checkpoint ); précédent : 003400; suivant : 003402

Medical history, lifestyle, and occupational risk factors for hairy cell leukemia: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.

Auteurs : Alain Monnereau [France] ; Susan L. Slager ; Ann Maree Hughes ; Alex Smith ; Bengt Glimelius ; Thomas M. Habermann ; Sonja I. Berndt ; Anthony Staines ; Aaron D. Norman ; James R. Cerhan ; Joshua N. Sampson ; Lindsay M. Morton ; Jacqueline Clavel

Source :

Journal of the National Cancer Institute. Monographs [ 1745-6614 ] ; 2014.

RBID : pubmed:25174032

Descripteurs français

KwdFr :
- Adulte, Adulte d'âge moyen, Amérique du Nord (ethnologie), Amérique du Nord (épidémiologie), Australie (ethnologie), Australie (épidémiologie), Comorbidité, Europe (ethnologie), Europe (épidémiologie), Exposition professionnelle, Facteurs de risque, Facteurs sexuels, Femelle, Humains, Jeune adulte, Leucémie à tricholeucocytes (épidémiologie), Leucémie à tricholeucocytes (étiologie), Mode de vie, Mâle, Odds ratio, Sujet âgé, Sujet âgé de 80 ans ou plus, Études cas-témoins.
MESH :
- ethnologie : Amérique du Nord, Australie, Europe.
- épidémiologie : Amérique du Nord, Australie, Europe, Leucémie à tricholeucocytes.
- étiologie : Leucémie à tricholeucocytes.
- Adulte, Adulte d'âge moyen, Comorbidité, Exposition professionnelle, Facteurs de risque, Facteurs sexuels, Femelle, Humains, Jeune adulte, Mode de vie, Mâle, Odds ratio, Sujet âgé, Sujet âgé de 80 ans ou plus, Études cas-témoins.
Wicri :
- geographic : Australie.

English descriptors

KwdEn :
- Adult, Aged, Aged, 80 and over, Australia (epidemiology), Australia (ethnology), Case-Control Studies, Comorbidity, Europe (epidemiology), Europe (ethnology), Female, Humans, Leukemia, Hairy Cell (epidemiology), Leukemia, Hairy Cell (etiology), Life Style, Male, Middle Aged, North America (epidemiology), North America (ethnology), Occupational Exposure, Odds Ratio, Risk Factors, Sex Factors, Young Adult.
MESH :
- geographic , epidemiology : Australia, Europe, North America.
- geographic , ethnology : Australia, Europe, North America.
- epidemiology : Leukemia, Hairy Cell.
- etiology : Leukemia, Hairy Cell.
- Adult, Aged, Aged, 80 and over, Case-Control Studies, Comorbidity, Female, Humans, Life Style, Male, Middle Aged, Occupational Exposure, Odds Ratio, Risk Factors, Sex Factors, Young Adult.

Abstract

Little is known about the etiology of hairy cell leukemia (HCL), a rare B-cell lymphoproliferative disorder with marked male predominance. Our aim was to identify key risk factors for HCL.

DOI: 10.1093/jncimonographs/lgu004
PubMed: 25174032

Affiliations:

France

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 003553
to stream PubMed, to step Curation: 003440

Links to Exploration step

pubmed:25174032

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Medical history, lifestyle, and occupational risk factors for hairy cell leukemia: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.</title>
<author><name sortKey="Monnereau, Alain" sort="Monnereau, Alain" uniqKey="Monnereau A" first="Alain" last="Monnereau">Alain Monnereau</name>
<affiliation wicri:level="1"><nlm:affiliation>Inserm, Centre for Research in Epidemiology and Population Health (CESP), Environmental Epidemiology of Cancer Group and Univ Paris Sud, Villejuif, France (AM, JC); Registry of Hematological Malignancies in Gironde, Bergonié Institute, Bordeaux, France (AM); Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN (SLS, TMH, ADN, JRC); National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australia (AMH); Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, Heslington, York, UK (ASm); Department of Radiology, Oncology and Radiation Science, Uppsala University, Uppsala, Sweden, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden (BG); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (SIB, JNS, LMM); School of Nursing and Human Sciences, Dublin City University, Dublin, Leinster, Ireland (ASt). A.Monnereau@bordeaux.unicancer.fr.</nlm:affiliation>
<country wicri:rule="url">France</country>
</affiliation>
</author>
<author><name sortKey="Slager, Susan L" sort="Slager, Susan L" uniqKey="Slager S" first="Susan L" last="Slager">Susan L. Slager</name>
<affiliation><nlm:affiliation>Inserm, Centre for Research in Epidemiology and Population Health (CESP), Environmental Epidemiology of Cancer Group and Univ Paris Sud, Villejuif, France (AM, JC); Registry of Hematological Malignancies in Gironde, Bergonié Institute, Bordeaux, France (AM); Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN (SLS, TMH, ADN, JRC); National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australia (AMH); Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, Heslington, York, UK (ASm); Department of Radiology, Oncology and Radiation Science, Uppsala University, Uppsala, Sweden, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden (BG); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (SIB, JNS, LMM); School of Nursing and Human Sciences, Dublin City University, Dublin, Leinster, Ireland (ASt).</nlm:affiliation>
<wicri:noCountry code="subField">Ireland (ASt)</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Hughes, Ann Maree" sort="Hughes, Ann Maree" uniqKey="Hughes A" first="Ann Maree" last="Hughes">Ann Maree Hughes</name>
<affiliation><nlm:affiliation>Inserm, Centre for Research in Epidemiology and Population Health (CESP), Environmental Epidemiology of Cancer Group and Univ Paris Sud, Villejuif, France (AM, JC); Registry of Hematological Malignancies in Gironde, Bergonié Institute, Bordeaux, France (AM); Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN (SLS, TMH, ADN, JRC); National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australia (AMH); Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, Heslington, York, UK (ASm); Department of Radiology, Oncology and Radiation Science, Uppsala University, Uppsala, Sweden, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden (BG); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (SIB, JNS, LMM); School of Nursing and Human Sciences, Dublin City University, Dublin, Leinster, Ireland (ASt).</nlm:affiliation>
<wicri:noCountry code="subField">Ireland (ASt)</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Smith, Alex" sort="Smith, Alex" uniqKey="Smith A" first="Alex" last="Smith">Alex Smith</name>
<affiliation><nlm:affiliation>Inserm, Centre for Research in Epidemiology and Population Health (CESP), Environmental Epidemiology of Cancer Group and Univ Paris Sud, Villejuif, France (AM, JC); Registry of Hematological Malignancies in Gironde, Bergonié Institute, Bordeaux, France (AM); Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN (SLS, TMH, ADN, JRC); National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australia (AMH); Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, Heslington, York, UK (ASm); Department of Radiology, Oncology and Radiation Science, Uppsala University, Uppsala, Sweden, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden (BG); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (SIB, JNS, LMM); School of Nursing and Human Sciences, Dublin City University, Dublin, Leinster, Ireland (ASt).</nlm:affiliation>
<wicri:noCountry code="subField">Ireland (ASt)</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Glimelius, Bengt" sort="Glimelius, Bengt" uniqKey="Glimelius B" first="Bengt" last="Glimelius">Bengt Glimelius</name>
<affiliation><nlm:affiliation>Inserm, Centre for Research in Epidemiology and Population Health (CESP), Environmental Epidemiology of Cancer Group and Univ Paris Sud, Villejuif, France (AM, JC); Registry of Hematological Malignancies in Gironde, Bergonié Institute, Bordeaux, France (AM); Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN (SLS, TMH, ADN, JRC); National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australia (AMH); Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, Heslington, York, UK (ASm); Department of Radiology, Oncology and Radiation Science, Uppsala University, Uppsala, Sweden, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden (BG); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (SIB, JNS, LMM); School of Nursing and Human Sciences, Dublin City University, Dublin, Leinster, Ireland (ASt).</nlm:affiliation>
<wicri:noCountry code="subField">Ireland (ASt)</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Habermann, Thomas M" sort="Habermann, Thomas M" uniqKey="Habermann T" first="Thomas M" last="Habermann">Thomas M. Habermann</name>
<affiliation><nlm:affiliation>Inserm, Centre for Research in Epidemiology and Population Health (CESP), Environmental Epidemiology of Cancer Group and Univ Paris Sud, Villejuif, France (AM, JC); Registry of Hematological Malignancies in Gironde, Bergonié Institute, Bordeaux, France (AM); Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN (SLS, TMH, ADN, JRC); National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australia (AMH); Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, Heslington, York, UK (ASm); Department of Radiology, Oncology and Radiation Science, Uppsala University, Uppsala, Sweden, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden (BG); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (SIB, JNS, LMM); School of Nursing and Human Sciences, Dublin City University, Dublin, Leinster, Ireland (ASt).</nlm:affiliation>
<wicri:noCountry code="subField">Ireland (ASt)</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Berndt, Sonja I" sort="Berndt, Sonja I" uniqKey="Berndt S" first="Sonja I" last="Berndt">Sonja I. Berndt</name>
<affiliation><nlm:affiliation>Inserm, Centre for Research in Epidemiology and Population Health (CESP), Environmental Epidemiology of Cancer Group and Univ Paris Sud, Villejuif, France (AM, JC); Registry of Hematological Malignancies in Gironde, Bergonié Institute, Bordeaux, France (AM); Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN (SLS, TMH, ADN, JRC); National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australia (AMH); Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, Heslington, York, UK (ASm); Department of Radiology, Oncology and Radiation Science, Uppsala University, Uppsala, Sweden, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden (BG); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (SIB, JNS, LMM); School of Nursing and Human Sciences, Dublin City University, Dublin, Leinster, Ireland (ASt).</nlm:affiliation>
<wicri:noCountry code="subField">Ireland (ASt)</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Staines, Anthony" sort="Staines, Anthony" uniqKey="Staines A" first="Anthony" last="Staines">Anthony Staines</name>
<affiliation><nlm:affiliation>Inserm, Centre for Research in Epidemiology and Population Health (CESP), Environmental Epidemiology of Cancer Group and Univ Paris Sud, Villejuif, France (AM, JC); Registry of Hematological Malignancies in Gironde, Bergonié Institute, Bordeaux, France (AM); Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN (SLS, TMH, ADN, JRC); National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australia (AMH); Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, Heslington, York, UK (ASm); Department of Radiology, Oncology and Radiation Science, Uppsala University, Uppsala, Sweden, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden (BG); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (SIB, JNS, LMM); School of Nursing and Human Sciences, Dublin City University, Dublin, Leinster, Ireland (ASt).</nlm:affiliation>
<wicri:noCountry code="subField">Ireland (ASt)</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Norman, Aaron D" sort="Norman, Aaron D" uniqKey="Norman A" first="Aaron D" last="Norman">Aaron D. Norman</name>
<affiliation><nlm:affiliation>Inserm, Centre for Research in Epidemiology and Population Health (CESP), Environmental Epidemiology of Cancer Group and Univ Paris Sud, Villejuif, France (AM, JC); Registry of Hematological Malignancies in Gironde, Bergonié Institute, Bordeaux, France (AM); Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN (SLS, TMH, ADN, JRC); National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australia (AMH); Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, Heslington, York, UK (ASm); Department of Radiology, Oncology and Radiation Science, Uppsala University, Uppsala, Sweden, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden (BG); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (SIB, JNS, LMM); School of Nursing and Human Sciences, Dublin City University, Dublin, Leinster, Ireland (ASt).</nlm:affiliation>
<wicri:noCountry code="subField">Ireland (ASt)</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Cerhan, James R" sort="Cerhan, James R" uniqKey="Cerhan J" first="James R" last="Cerhan">James R. Cerhan</name>
<affiliation><nlm:affiliation>Inserm, Centre for Research in Epidemiology and Population Health (CESP), Environmental Epidemiology of Cancer Group and Univ Paris Sud, Villejuif, France (AM, JC); Registry of Hematological Malignancies in Gironde, Bergonié Institute, Bordeaux, France (AM); Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN (SLS, TMH, ADN, JRC); National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australia (AMH); Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, Heslington, York, UK (ASm); Department of Radiology, Oncology and Radiation Science, Uppsala University, Uppsala, Sweden, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden (BG); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (SIB, JNS, LMM); School of Nursing and Human Sciences, Dublin City University, Dublin, Leinster, Ireland (ASt).</nlm:affiliation>
<wicri:noCountry code="subField">Ireland (ASt)</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Sampson, Joshua N" sort="Sampson, Joshua N" uniqKey="Sampson J" first="Joshua N" last="Sampson">Joshua N. Sampson</name>
<affiliation><nlm:affiliation>Inserm, Centre for Research in Epidemiology and Population Health (CESP), Environmental Epidemiology of Cancer Group and Univ Paris Sud, Villejuif, France (AM, JC); Registry of Hematological Malignancies in Gironde, Bergonié Institute, Bordeaux, France (AM); Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN (SLS, TMH, ADN, JRC); National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australia (AMH); Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, Heslington, York, UK (ASm); Department of Radiology, Oncology and Radiation Science, Uppsala University, Uppsala, Sweden, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden (BG); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (SIB, JNS, LMM); School of Nursing and Human Sciences, Dublin City University, Dublin, Leinster, Ireland (ASt).</nlm:affiliation>
<wicri:noCountry code="subField">Ireland (ASt)</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Morton, Lindsay M" sort="Morton, Lindsay M" uniqKey="Morton L" first="Lindsay M" last="Morton">Lindsay M. Morton</name>
<affiliation><nlm:affiliation>Inserm, Centre for Research in Epidemiology and Population Health (CESP), Environmental Epidemiology of Cancer Group and Univ Paris Sud, Villejuif, France (AM, JC); Registry of Hematological Malignancies in Gironde, Bergonié Institute, Bordeaux, France (AM); Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN (SLS, TMH, ADN, JRC); National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australia (AMH); Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, Heslington, York, UK (ASm); Department of Radiology, Oncology and Radiation Science, Uppsala University, Uppsala, Sweden, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden (BG); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (SIB, JNS, LMM); School of Nursing and Human Sciences, Dublin City University, Dublin, Leinster, Ireland (ASt).</nlm:affiliation>
<wicri:noCountry code="subField">Ireland (ASt)</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Clavel, Jacqueline" sort="Clavel, Jacqueline" uniqKey="Clavel J" first="Jacqueline" last="Clavel">Jacqueline Clavel</name>
<affiliation><nlm:affiliation>Inserm, Centre for Research in Epidemiology and Population Health (CESP), Environmental Epidemiology of Cancer Group and Univ Paris Sud, Villejuif, France (AM, JC); Registry of Hematological Malignancies in Gironde, Bergonié Institute, Bordeaux, France (AM); Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN (SLS, TMH, ADN, JRC); National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australia (AMH); Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, Heslington, York, UK (ASm); Department of Radiology, Oncology and Radiation Science, Uppsala University, Uppsala, Sweden, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden (BG); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (SIB, JNS, LMM); School of Nursing and Human Sciences, Dublin City University, Dublin, Leinster, Ireland (ASt).</nlm:affiliation>
<wicri:noCountry code="subField">Ireland (ASt)</wicri:noCountry>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:25174032</idno>
<idno type="pmid">25174032</idno>
<idno type="doi">10.1093/jncimonographs/lgu004</idno>
<idno type="wicri:Area/PubMed/Corpus">003553</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003553</idno>
<idno type="wicri:Area/PubMed/Curation">003440</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003440</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003440</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003440</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Medical history, lifestyle, and occupational risk factors for hairy cell leukemia: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.</title>
<author><name sortKey="Monnereau, Alain" sort="Monnereau, Alain" uniqKey="Monnereau A" first="Alain" last="Monnereau">Alain Monnereau</name>
<affiliation wicri:level="1"><nlm:affiliation>Inserm, Centre for Research in Epidemiology and Population Health (CESP), Environmental Epidemiology of Cancer Group and Univ Paris Sud, Villejuif, France (AM, JC); Registry of Hematological Malignancies in Gironde, Bergonié Institute, Bordeaux, France (AM); Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN (SLS, TMH, ADN, JRC); National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australia (AMH); Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, Heslington, York, UK (ASm); Department of Radiology, Oncology and Radiation Science, Uppsala University, Uppsala, Sweden, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden (BG); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (SIB, JNS, LMM); School of Nursing and Human Sciences, Dublin City University, Dublin, Leinster, Ireland (ASt). A.Monnereau@bordeaux.unicancer.fr.</nlm:affiliation>
<country wicri:rule="url">France</country>
</affiliation>
</author>
<author><name sortKey="Slager, Susan L" sort="Slager, Susan L" uniqKey="Slager S" first="Susan L" last="Slager">Susan L. Slager</name>
<affiliation><nlm:affiliation>Inserm, Centre for Research in Epidemiology and Population Health (CESP), Environmental Epidemiology of Cancer Group and Univ Paris Sud, Villejuif, France (AM, JC); Registry of Hematological Malignancies in Gironde, Bergonié Institute, Bordeaux, France (AM); Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN (SLS, TMH, ADN, JRC); National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australia (AMH); Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, Heslington, York, UK (ASm); Department of Radiology, Oncology and Radiation Science, Uppsala University, Uppsala, Sweden, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden (BG); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (SIB, JNS, LMM); School of Nursing and Human Sciences, Dublin City University, Dublin, Leinster, Ireland (ASt).</nlm:affiliation>
<wicri:noCountry code="subField">Ireland (ASt)</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Hughes, Ann Maree" sort="Hughes, Ann Maree" uniqKey="Hughes A" first="Ann Maree" last="Hughes">Ann Maree Hughes</name>
<affiliation><nlm:affiliation>Inserm, Centre for Research in Epidemiology and Population Health (CESP), Environmental Epidemiology of Cancer Group and Univ Paris Sud, Villejuif, France (AM, JC); Registry of Hematological Malignancies in Gironde, Bergonié Institute, Bordeaux, France (AM); Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN (SLS, TMH, ADN, JRC); National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australia (AMH); Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, Heslington, York, UK (ASm); Department of Radiology, Oncology and Radiation Science, Uppsala University, Uppsala, Sweden, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden (BG); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (SIB, JNS, LMM); School of Nursing and Human Sciences, Dublin City University, Dublin, Leinster, Ireland (ASt).</nlm:affiliation>
<wicri:noCountry code="subField">Ireland (ASt)</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Smith, Alex" sort="Smith, Alex" uniqKey="Smith A" first="Alex" last="Smith">Alex Smith</name>
<affiliation><nlm:affiliation>Inserm, Centre for Research in Epidemiology and Population Health (CESP), Environmental Epidemiology of Cancer Group and Univ Paris Sud, Villejuif, France (AM, JC); Registry of Hematological Malignancies in Gironde, Bergonié Institute, Bordeaux, France (AM); Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN (SLS, TMH, ADN, JRC); National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australia (AMH); Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, Heslington, York, UK (ASm); Department of Radiology, Oncology and Radiation Science, Uppsala University, Uppsala, Sweden, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden (BG); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (SIB, JNS, LMM); School of Nursing and Human Sciences, Dublin City University, Dublin, Leinster, Ireland (ASt).</nlm:affiliation>
<wicri:noCountry code="subField">Ireland (ASt)</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Glimelius, Bengt" sort="Glimelius, Bengt" uniqKey="Glimelius B" first="Bengt" last="Glimelius">Bengt Glimelius</name>
<affiliation><nlm:affiliation>Inserm, Centre for Research in Epidemiology and Population Health (CESP), Environmental Epidemiology of Cancer Group and Univ Paris Sud, Villejuif, France (AM, JC); Registry of Hematological Malignancies in Gironde, Bergonié Institute, Bordeaux, France (AM); Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN (SLS, TMH, ADN, JRC); National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australia (AMH); Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, Heslington, York, UK (ASm); Department of Radiology, Oncology and Radiation Science, Uppsala University, Uppsala, Sweden, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden (BG); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (SIB, JNS, LMM); School of Nursing and Human Sciences, Dublin City University, Dublin, Leinster, Ireland (ASt).</nlm:affiliation>
<wicri:noCountry code="subField">Ireland (ASt)</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Habermann, Thomas M" sort="Habermann, Thomas M" uniqKey="Habermann T" first="Thomas M" last="Habermann">Thomas M. Habermann</name>
<affiliation><nlm:affiliation>Inserm, Centre for Research in Epidemiology and Population Health (CESP), Environmental Epidemiology of Cancer Group and Univ Paris Sud, Villejuif, France (AM, JC); Registry of Hematological Malignancies in Gironde, Bergonié Institute, Bordeaux, France (AM); Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN (SLS, TMH, ADN, JRC); National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australia (AMH); Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, Heslington, York, UK (ASm); Department of Radiology, Oncology and Radiation Science, Uppsala University, Uppsala, Sweden, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden (BG); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (SIB, JNS, LMM); School of Nursing and Human Sciences, Dublin City University, Dublin, Leinster, Ireland (ASt).</nlm:affiliation>
<wicri:noCountry code="subField">Ireland (ASt)</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Berndt, Sonja I" sort="Berndt, Sonja I" uniqKey="Berndt S" first="Sonja I" last="Berndt">Sonja I. Berndt</name>
<affiliation><nlm:affiliation>Inserm, Centre for Research in Epidemiology and Population Health (CESP), Environmental Epidemiology of Cancer Group and Univ Paris Sud, Villejuif, France (AM, JC); Registry of Hematological Malignancies in Gironde, Bergonié Institute, Bordeaux, France (AM); Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN (SLS, TMH, ADN, JRC); National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australia (AMH); Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, Heslington, York, UK (ASm); Department of Radiology, Oncology and Radiation Science, Uppsala University, Uppsala, Sweden, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden (BG); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (SIB, JNS, LMM); School of Nursing and Human Sciences, Dublin City University, Dublin, Leinster, Ireland (ASt).</nlm:affiliation>
<wicri:noCountry code="subField">Ireland (ASt)</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Staines, Anthony" sort="Staines, Anthony" uniqKey="Staines A" first="Anthony" last="Staines">Anthony Staines</name>
<affiliation><nlm:affiliation>Inserm, Centre for Research in Epidemiology and Population Health (CESP), Environmental Epidemiology of Cancer Group and Univ Paris Sud, Villejuif, France (AM, JC); Registry of Hematological Malignancies in Gironde, Bergonié Institute, Bordeaux, France (AM); Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN (SLS, TMH, ADN, JRC); National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australia (AMH); Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, Heslington, York, UK (ASm); Department of Radiology, Oncology and Radiation Science, Uppsala University, Uppsala, Sweden, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden (BG); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (SIB, JNS, LMM); School of Nursing and Human Sciences, Dublin City University, Dublin, Leinster, Ireland (ASt).</nlm:affiliation>
<wicri:noCountry code="subField">Ireland (ASt)</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Norman, Aaron D" sort="Norman, Aaron D" uniqKey="Norman A" first="Aaron D" last="Norman">Aaron D. Norman</name>
<affiliation><nlm:affiliation>Inserm, Centre for Research in Epidemiology and Population Health (CESP), Environmental Epidemiology of Cancer Group and Univ Paris Sud, Villejuif, France (AM, JC); Registry of Hematological Malignancies in Gironde, Bergonié Institute, Bordeaux, France (AM); Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN (SLS, TMH, ADN, JRC); National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australia (AMH); Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, Heslington, York, UK (ASm); Department of Radiology, Oncology and Radiation Science, Uppsala University, Uppsala, Sweden, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden (BG); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (SIB, JNS, LMM); School of Nursing and Human Sciences, Dublin City University, Dublin, Leinster, Ireland (ASt).</nlm:affiliation>
<wicri:noCountry code="subField">Ireland (ASt)</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Cerhan, James R" sort="Cerhan, James R" uniqKey="Cerhan J" first="James R" last="Cerhan">James R. Cerhan</name>
<affiliation><nlm:affiliation>Inserm, Centre for Research in Epidemiology and Population Health (CESP), Environmental Epidemiology of Cancer Group and Univ Paris Sud, Villejuif, France (AM, JC); Registry of Hematological Malignancies in Gironde, Bergonié Institute, Bordeaux, France (AM); Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN (SLS, TMH, ADN, JRC); National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australia (AMH); Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, Heslington, York, UK (ASm); Department of Radiology, Oncology and Radiation Science, Uppsala University, Uppsala, Sweden, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden (BG); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (SIB, JNS, LMM); School of Nursing and Human Sciences, Dublin City University, Dublin, Leinster, Ireland (ASt).</nlm:affiliation>
<wicri:noCountry code="subField">Ireland (ASt)</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Sampson, Joshua N" sort="Sampson, Joshua N" uniqKey="Sampson J" first="Joshua N" last="Sampson">Joshua N. Sampson</name>
<affiliation><nlm:affiliation>Inserm, Centre for Research in Epidemiology and Population Health (CESP), Environmental Epidemiology of Cancer Group and Univ Paris Sud, Villejuif, France (AM, JC); Registry of Hematological Malignancies in Gironde, Bergonié Institute, Bordeaux, France (AM); Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN (SLS, TMH, ADN, JRC); National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australia (AMH); Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, Heslington, York, UK (ASm); Department of Radiology, Oncology and Radiation Science, Uppsala University, Uppsala, Sweden, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden (BG); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (SIB, JNS, LMM); School of Nursing and Human Sciences, Dublin City University, Dublin, Leinster, Ireland (ASt).</nlm:affiliation>
<wicri:noCountry code="subField">Ireland (ASt)</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Morton, Lindsay M" sort="Morton, Lindsay M" uniqKey="Morton L" first="Lindsay M" last="Morton">Lindsay M. Morton</name>
<affiliation><nlm:affiliation>Inserm, Centre for Research in Epidemiology and Population Health (CESP), Environmental Epidemiology of Cancer Group and Univ Paris Sud, Villejuif, France (AM, JC); Registry of Hematological Malignancies in Gironde, Bergonié Institute, Bordeaux, France (AM); Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN (SLS, TMH, ADN, JRC); National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australia (AMH); Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, Heslington, York, UK (ASm); Department of Radiology, Oncology and Radiation Science, Uppsala University, Uppsala, Sweden, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden (BG); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (SIB, JNS, LMM); School of Nursing and Human Sciences, Dublin City University, Dublin, Leinster, Ireland (ASt).</nlm:affiliation>
<wicri:noCountry code="subField">Ireland (ASt)</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Clavel, Jacqueline" sort="Clavel, Jacqueline" uniqKey="Clavel J" first="Jacqueline" last="Clavel">Jacqueline Clavel</name>
<affiliation><nlm:affiliation>Inserm, Centre for Research in Epidemiology and Population Health (CESP), Environmental Epidemiology of Cancer Group and Univ Paris Sud, Villejuif, France (AM, JC); Registry of Hematological Malignancies in Gironde, Bergonié Institute, Bordeaux, France (AM); Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN (SLS, TMH, ADN, JRC); National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australia (AMH); Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, Heslington, York, UK (ASm); Department of Radiology, Oncology and Radiation Science, Uppsala University, Uppsala, Sweden, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden (BG); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (SIB, JNS, LMM); School of Nursing and Human Sciences, Dublin City University, Dublin, Leinster, Ireland (ASt).</nlm:affiliation>
<wicri:noCountry code="subField">Ireland (ASt)</wicri:noCountry>
</affiliation>
</author>
</analytic>
<series><title level="j">Journal of the National Cancer Institute. Monographs</title>
<idno type="eISSN">1745-6614</idno>
<imprint><date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Australia (epidemiology)</term>
<term>Australia (ethnology)</term>
<term>Case-Control Studies</term>
<term>Comorbidity</term>
<term>Europe (epidemiology)</term>
<term>Europe (ethnology)</term>
<term>Female</term>
<term>Humans</term>
<term>Leukemia, Hairy Cell (epidemiology)</term>
<term>Leukemia, Hairy Cell (etiology)</term>
<term>Life Style</term>
<term>Male</term>
<term>Middle Aged</term>
<term>North America (epidemiology)</term>
<term>North America (ethnology)</term>
<term>Occupational Exposure</term>
<term>Odds Ratio</term>
<term>Risk Factors</term>
<term>Sex Factors</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Amérique du Nord (ethnologie)</term>
<term>Amérique du Nord (épidémiologie)</term>
<term>Australie (ethnologie)</term>
<term>Australie (épidémiologie)</term>
<term>Comorbidité</term>
<term>Europe (ethnologie)</term>
<term>Europe (épidémiologie)</term>
<term>Exposition professionnelle</term>
<term>Facteurs de risque</term>
<term>Facteurs sexuels</term>
<term>Femelle</term>
<term>Humains</term>
<term>Jeune adulte</term>
<term>Leucémie à tricholeucocytes (épidémiologie)</term>
<term>Leucémie à tricholeucocytes (étiologie)</term>
<term>Mode de vie</term>
<term>Mâle</term>
<term>Odds ratio</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Études cas-témoins</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Australia</term>
<term>Europe</term>
<term>North America</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="ethnology" xml:lang="en"><term>Australia</term>
<term>Europe</term>
<term>North America</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Leukemia, Hairy Cell</term>
</keywords>
<keywords scheme="MESH" qualifier="ethnologie" xml:lang="fr"><term>Amérique du Nord</term>
<term>Australie</term>
<term>Europe</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Leukemia, Hairy Cell</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Amérique du Nord</term>
<term>Australie</term>
<term>Europe</term>
<term>Leucémie à tricholeucocytes</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Leucémie à tricholeucocytes</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Case-Control Studies</term>
<term>Comorbidity</term>
<term>Female</term>
<term>Humans</term>
<term>Life Style</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Occupational Exposure</term>
<term>Odds Ratio</term>
<term>Risk Factors</term>
<term>Sex Factors</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Comorbidité</term>
<term>Exposition professionnelle</term>
<term>Facteurs de risque</term>
<term>Facteurs sexuels</term>
<term>Femelle</term>
<term>Humains</term>
<term>Jeune adulte</term>
<term>Mode de vie</term>
<term>Mâle</term>
<term>Odds ratio</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Études cas-témoins</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Australie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Little is known about the etiology of hairy cell leukemia (HCL), a rare B-cell lymphoproliferative disorder with marked male predominance. Our aim was to identify key risk factors for HCL.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25174032</PMID>
<DateCreated><Year>2014</Year>
<Month>09</Month>
<Day>01</Day>
</DateCreated>
<DateCompleted><Year>2015</Year>
<Month>05</Month>
<Day>22</Day>
</DateCompleted>
<DateRevised><Year>2016</Year>
<Month>10</Month>
<Day>19</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1745-6614</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>2014</Volume>
<Issue>48</Issue>
<PubDate><Year>2014</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of the National Cancer Institute. Monographs</Title>
<ISOAbbreviation>J. Natl. Cancer Inst. Monographs</ISOAbbreviation>
</Journal>
<ArticleTitle>Medical history, lifestyle, and occupational risk factors for hairy cell leukemia: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.</ArticleTitle>
<Pagination><MedlinePgn>115-24</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1093/jncimonographs/lgu004</ELocationID>
<Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Little is known about the etiology of hairy cell leukemia (HCL), a rare B-cell lymphoproliferative disorder with marked male predominance. Our aim was to identify key risk factors for HCL.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">A pooled analysis of individual-level data for 154 histologically confirmed HCL cases and 8834 controls from five case-control studies, conducted in Europe and Australia, was undertaken. Age-, race and/or ethnicity-, sex-, and study-adjusted odds ratios (OR) and 95% confidence intervals (CI) were estimated using unconditional logistic regression.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The usual patterns for age and sex in HCL were observed, with a median age of 55 years and sex ratio of 3.7 males to females. Cigarette smoking was inversely associated with HCL (OR = 0.51, 95% CI = 0.37 to 0.71) with dose-response relationships observed for duration, frequency, and lifetime cigarette smoking (P(trend) < .001). In contrast, occupation as a farmer was positively associated with HCL (OR = 2.34, 95% CI = 1.36 to 4.01), with a dose-response relationship observed for duration (OR = 1.82, 95% CI = 0.85 to 3.88 for ≤ 10 years vs never; and OR = 2.98, 95% CI = 1.50 to 5.93 for >10 years vs never; P(trend) = .025). Adult height was also positively associated with HCL (OR = 2.69, 95% CI = 1.39 to 5.29 for upper vs lower quartile of height). The observed associations remained consistent in multivariate analysis.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our observations of an increased risk of HCL from farming exposures and decreased risk from smoking exposures, independent of one another, support a multifactorial origin and an etiological specificity of HCL compared with other non-Hodgkin lymphoma subtypes. The positive association with height is a novel finding that needs replication.</AbstractText>
<CopyrightInformation>Published by Oxford University Press 2014.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Monnereau</LastName>
<ForeName>Alain</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Inserm, Centre for Research in Epidemiology and Population Health (CESP), Environmental Epidemiology of Cancer Group and Univ Paris Sud, Villejuif, France (AM, JC); Registry of Hematological Malignancies in Gironde, Bergonié Institute, Bordeaux, France (AM); Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN (SLS, TMH, ADN, JRC); National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australia (AMH); Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, Heslington, York, UK (ASm); Department of Radiology, Oncology and Radiation Science, Uppsala University, Uppsala, Sweden, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden (BG); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (SIB, JNS, LMM); School of Nursing and Human Sciences, Dublin City University, Dublin, Leinster, Ireland (ASt). A.Monnereau@bordeaux.unicancer.fr.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Slager</LastName>
<ForeName>Susan L</ForeName>
<Initials>SL</Initials>
<AffiliationInfo><Affiliation>Inserm, Centre for Research in Epidemiology and Population Health (CESP), Environmental Epidemiology of Cancer Group and Univ Paris Sud, Villejuif, France (AM, JC); Registry of Hematological Malignancies in Gironde, Bergonié Institute, Bordeaux, France (AM); Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN (SLS, TMH, ADN, JRC); National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australia (AMH); Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, Heslington, York, UK (ASm); Department of Radiology, Oncology and Radiation Science, Uppsala University, Uppsala, Sweden, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden (BG); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (SIB, JNS, LMM); School of Nursing and Human Sciences, Dublin City University, Dublin, Leinster, Ireland (ASt).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Hughes</LastName>
<ForeName>Ann Maree</ForeName>
<Initials>AM</Initials>
<AffiliationInfo><Affiliation>Inserm, Centre for Research in Epidemiology and Population Health (CESP), Environmental Epidemiology of Cancer Group and Univ Paris Sud, Villejuif, France (AM, JC); Registry of Hematological Malignancies in Gironde, Bergonié Institute, Bordeaux, France (AM); Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN (SLS, TMH, ADN, JRC); National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australia (AMH); Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, Heslington, York, UK (ASm); Department of Radiology, Oncology and Radiation Science, Uppsala University, Uppsala, Sweden, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden (BG); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (SIB, JNS, LMM); School of Nursing and Human Sciences, Dublin City University, Dublin, Leinster, Ireland (ASt).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Smith</LastName>
<ForeName>Alex</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Inserm, Centre for Research in Epidemiology and Population Health (CESP), Environmental Epidemiology of Cancer Group and Univ Paris Sud, Villejuif, France (AM, JC); Registry of Hematological Malignancies in Gironde, Bergonié Institute, Bordeaux, France (AM); Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN (SLS, TMH, ADN, JRC); National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australia (AMH); Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, Heslington, York, UK (ASm); Department of Radiology, Oncology and Radiation Science, Uppsala University, Uppsala, Sweden, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden (BG); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (SIB, JNS, LMM); School of Nursing and Human Sciences, Dublin City University, Dublin, Leinster, Ireland (ASt).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Glimelius</LastName>
<ForeName>Bengt</ForeName>
<Initials>B</Initials>
<AffiliationInfo><Affiliation>Inserm, Centre for Research in Epidemiology and Population Health (CESP), Environmental Epidemiology of Cancer Group and Univ Paris Sud, Villejuif, France (AM, JC); Registry of Hematological Malignancies in Gironde, Bergonié Institute, Bordeaux, France (AM); Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN (SLS, TMH, ADN, JRC); National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australia (AMH); Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, Heslington, York, UK (ASm); Department of Radiology, Oncology and Radiation Science, Uppsala University, Uppsala, Sweden, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden (BG); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (SIB, JNS, LMM); School of Nursing and Human Sciences, Dublin City University, Dublin, Leinster, Ireland (ASt).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Habermann</LastName>
<ForeName>Thomas M</ForeName>
<Initials>TM</Initials>
<AffiliationInfo><Affiliation>Inserm, Centre for Research in Epidemiology and Population Health (CESP), Environmental Epidemiology of Cancer Group and Univ Paris Sud, Villejuif, France (AM, JC); Registry of Hematological Malignancies in Gironde, Bergonié Institute, Bordeaux, France (AM); Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN (SLS, TMH, ADN, JRC); National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australia (AMH); Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, Heslington, York, UK (ASm); Department of Radiology, Oncology and Radiation Science, Uppsala University, Uppsala, Sweden, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden (BG); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (SIB, JNS, LMM); School of Nursing and Human Sciences, Dublin City University, Dublin, Leinster, Ireland (ASt).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Berndt</LastName>
<ForeName>Sonja I</ForeName>
<Initials>SI</Initials>
<AffiliationInfo><Affiliation>Inserm, Centre for Research in Epidemiology and Population Health (CESP), Environmental Epidemiology of Cancer Group and Univ Paris Sud, Villejuif, France (AM, JC); Registry of Hematological Malignancies in Gironde, Bergonié Institute, Bordeaux, France (AM); Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN (SLS, TMH, ADN, JRC); National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australia (AMH); Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, Heslington, York, UK (ASm); Department of Radiology, Oncology and Radiation Science, Uppsala University, Uppsala, Sweden, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden (BG); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (SIB, JNS, LMM); School of Nursing and Human Sciences, Dublin City University, Dublin, Leinster, Ireland (ASt).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Staines</LastName>
<ForeName>Anthony</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Inserm, Centre for Research in Epidemiology and Population Health (CESP), Environmental Epidemiology of Cancer Group and Univ Paris Sud, Villejuif, France (AM, JC); Registry of Hematological Malignancies in Gironde, Bergonié Institute, Bordeaux, France (AM); Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN (SLS, TMH, ADN, JRC); National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australia (AMH); Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, Heslington, York, UK (ASm); Department of Radiology, Oncology and Radiation Science, Uppsala University, Uppsala, Sweden, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden (BG); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (SIB, JNS, LMM); School of Nursing and Human Sciences, Dublin City University, Dublin, Leinster, Ireland (ASt).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Norman</LastName>
<ForeName>Aaron D</ForeName>
<Initials>AD</Initials>
<AffiliationInfo><Affiliation>Inserm, Centre for Research in Epidemiology and Population Health (CESP), Environmental Epidemiology of Cancer Group and Univ Paris Sud, Villejuif, France (AM, JC); Registry of Hematological Malignancies in Gironde, Bergonié Institute, Bordeaux, France (AM); Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN (SLS, TMH, ADN, JRC); National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australia (AMH); Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, Heslington, York, UK (ASm); Department of Radiology, Oncology and Radiation Science, Uppsala University, Uppsala, Sweden, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden (BG); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (SIB, JNS, LMM); School of Nursing and Human Sciences, Dublin City University, Dublin, Leinster, Ireland (ASt).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Cerhan</LastName>
<ForeName>James R</ForeName>
<Initials>JR</Initials>
<AffiliationInfo><Affiliation>Inserm, Centre for Research in Epidemiology and Population Health (CESP), Environmental Epidemiology of Cancer Group and Univ Paris Sud, Villejuif, France (AM, JC); Registry of Hematological Malignancies in Gironde, Bergonié Institute, Bordeaux, France (AM); Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN (SLS, TMH, ADN, JRC); National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australia (AMH); Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, Heslington, York, UK (ASm); Department of Radiology, Oncology and Radiation Science, Uppsala University, Uppsala, Sweden, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden (BG); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (SIB, JNS, LMM); School of Nursing and Human Sciences, Dublin City University, Dublin, Leinster, Ireland (ASt).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Sampson</LastName>
<ForeName>Joshua N</ForeName>
<Initials>JN</Initials>
<AffiliationInfo><Affiliation>Inserm, Centre for Research in Epidemiology and Population Health (CESP), Environmental Epidemiology of Cancer Group and Univ Paris Sud, Villejuif, France (AM, JC); Registry of Hematological Malignancies in Gironde, Bergonié Institute, Bordeaux, France (AM); Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN (SLS, TMH, ADN, JRC); National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australia (AMH); Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, Heslington, York, UK (ASm); Department of Radiology, Oncology and Radiation Science, Uppsala University, Uppsala, Sweden, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden (BG); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (SIB, JNS, LMM); School of Nursing and Human Sciences, Dublin City University, Dublin, Leinster, Ireland (ASt).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Morton</LastName>
<ForeName>Lindsay M</ForeName>
<Initials>LM</Initials>
<AffiliationInfo><Affiliation>Inserm, Centre for Research in Epidemiology and Population Health (CESP), Environmental Epidemiology of Cancer Group and Univ Paris Sud, Villejuif, France (AM, JC); Registry of Hematological Malignancies in Gironde, Bergonié Institute, Bordeaux, France (AM); Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN (SLS, TMH, ADN, JRC); National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australia (AMH); Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, Heslington, York, UK (ASm); Department of Radiology, Oncology and Radiation Science, Uppsala University, Uppsala, Sweden, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden (BG); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (SIB, JNS, LMM); School of Nursing and Human Sciences, Dublin City University, Dublin, Leinster, Ireland (ASt).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Clavel</LastName>
<ForeName>Jacqueline</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Inserm, Centre for Research in Epidemiology and Population Health (CESP), Environmental Epidemiology of Cancer Group and Univ Paris Sud, Villejuif, France (AM, JC); Registry of Hematological Malignancies in Gironde, Bergonié Institute, Bordeaux, France (AM); Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN (SLS, TMH, ADN, JRC); National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australia (AMH); Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, Heslington, York, UK (ASm); Department of Radiology, Oncology and Radiation Science, Uppsala University, Uppsala, Sweden, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden (BG); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (SIB, JNS, LMM); School of Nursing and Human Sciences, Dublin City University, Dublin, Leinster, Ireland (ASt).</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>R01CA100555</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>CA62006</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>N01-PC-67008</GrantID>
<Acronym>PC</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>N02-PC-71105</GrantID>
<Acronym>PC</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R01CA104682</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>N01-PC-67010</GrantID>
<Acronym>PC</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>5R01 CA69669</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>UL 1 RR024160</GrantID>
<Acronym>RR</Acronym>
<Agency>NCRR NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>N01-CP-ES-11027</GrantID>
<Acronym>CP</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>N01-PC-65064</GrantID>
<Acronym>PC</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>P50 CA130805</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>CA143947</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R01CA154643-01A1</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>N01-PC-67009</GrantID>
<Acronym>PC</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><Agency>Intramural NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><Agency>Canadian Institutes of Health Research</Agency>
<Country>Canada</Country>
</Grant>
<Grant><GrantID>R01CA122663</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>UL1 TR000135</GrantID>
<Acronym>TR</Acronym>
<Agency>NCATS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R01 CA92153-S1</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>CA165923</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R01 CA50850</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>T32 HL007152</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R01 CA92153</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>CA51086</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R03CA132153</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>P50 CA097274</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>CA150037</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>K23 CA102216</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R01CA45614</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R01 CA14690</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R01CA087014</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>P50 CA97274</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>N01-CO-12400</GrantID>
<Acronym>CO</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>U01 CA118444</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R03CA125831</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>N01-CP-95618</GrantID>
<Acronym>CP</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D017418">Meta-Analysis</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>J Natl Cancer Inst Monogr</MedlineTA>
<NlmUniqueID>9011255</NlmUniqueID>
<ISSNLinking>1052-6773</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Br J Haematol. 1997 Apr;97(1):240-1</RefSource>
<PMID Version="1">9136973</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Occup Environ Med. 1996 Aug;53(8):533-9</RefSource>
<PMID Version="1">8983464</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 1998 Jun;77(11):2048-52</RefSource>
<PMID Version="1">9667691</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Br J Haematol. 1999 Aug;106(2):281-95</RefSource>
<PMID Version="1">10460584</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Blood. 1958 Jul;13(7):609-30</RefSource>
<PMID Version="1">13560561</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2005 Feb 2;97(3):199-209</RefSource>
<PMID Version="1">15687363</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Pharmacol Rev. 2005 Mar;57(1):79-115</RefSource>
<PMID Version="1">15734728</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2005 Nov 17;353(20):2135-47</RefSource>
<PMID Version="1">16291983</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nat Rev Cancer. 2006 Jun;6(6):437-48</RefSource>
<PMID Version="1">16723990</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2006 Aug 15;119(4):901-8</RefSource>
<PMID Version="1">16557575</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Eur J Haematol. 2006 Nov;77(5):372-7</RefSource>
<PMID Version="1">17044834</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Occup Environ Med. 2007 Dec;49(12):1339-50</RefSource>
<PMID Version="1">18231081</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Med. 2008 Jun;121(6):501-508.e3</RefSource>
<PMID Version="1">18501231</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Br J Haematol. 2008 Jul;142(1):45-51</RefSource>
<PMID Version="1">18477040</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Causes Control. 2008 Dec;19(10):1147-60</RefSource>
<PMID Version="1">18781390</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Occup Environ Med. 2009 May;66(5):291-8</RefSource>
<PMID Version="1">19017688</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Leuk Lymphoma. 2009 Oct;50 Suppl 1:8-11</RefSource>
<PMID Version="1">19814691</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Toxicol Appl Pharmacol. 2010 Feb 1;242(3):299-309</RefSource>
<PMID Version="1">19896492</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Hematol Oncol. 2010;3:35</RefSource>
<PMID Version="1">20920342</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Blood. 2010 Nov 18;116(20):e90-8</RefSource>
<PMID Version="1">20699439</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Physiol Cell Physiol. 2011 Feb;300(2):C256-65</RefSource>
<PMID Version="1">21123734</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2011 Jun 16;364(24):2305-15</RefSource>
<PMID Version="1">21663470</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet Oncol. 2011 Aug;12(8):785-94</RefSource>
<PMID Version="1">21782509</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 2011 Nov 22;105(11):1684-92</RefSource>
<PMID Version="1">22045184</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Causes Control. 2012 Oct;23(10):1615-24</RefSource>
<PMID Version="1">22843022</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Epidemiol. 2012 Dec;41(6):1694-705</RefSource>
<PMID Version="1">23064412</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 2013 Jun 11;108(11):2390-8</RefSource>
<PMID Version="1">23640394</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2013 Jun 19;105(12):860-8</RefSource>
<PMID Version="1">23708052</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Leuk Lymphoma. 1998 Mar;29(1-2):193-7</RefSource>
<PMID Version="1">9638989</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Environ Health Perspect. 2000 May;108(5):441-5</RefSource>
<PMID Version="1">10811571</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Epidemiol Community Health. 2000 Jun;54(6):431-6</RefSource>
<PMID Version="1">10818118</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nat Rev Immunol. 2002 May;2(5):372-7</RefSource>
<PMID Version="1">12033743</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Stat Med. 2002 Jun 15;21(11):1539-58</RefSource>
<PMID Version="1">12111919</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet Oncol. 2002 Aug;3(8):470-80</RefSource>
<PMID Version="1">12147433</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Leuk Lymphoma. 2002 May;43(5):1043-9</RefSource>
<PMID Version="1">12148884</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Epidemiol Rev. 2001;23(2):313-42</RefSource>
<PMID Version="1">12192740</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Endocrinol Metab. 2004 May;89(5):2414-20</RefSource>
<PMID Version="1">15126572</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2004 Dec 10;112(5):865-71</RefSource>
<PMID Version="1">15386383</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Epidemiol. 1985 May;121(5):675-83</RefSource>
<PMID Version="1">4014159</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 1990 Jun 15;50(12):3605-9</RefSource>
<PMID Version="1">2340508</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Br J Haematol. 1993 Dec;85(4):714-7</RefSource>
<PMID Version="1">7918034</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Br J Haematol. 1995 Apr;89(4):942-3</RefSource>
<PMID Version="1">7772541</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Br J Haematol. 1995 Sep;91(1):154-61</RefSource>
<PMID Version="1">7577624</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Scand J Work Environ Health. 1996 Aug;22(4):285-93</RefSource>
<PMID Version="1">8881017</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Eur J Cancer Prev. 1997 Oct;6(5):467-72</RefSource>
<PMID Version="1">9466117</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001315" MajorTopicYN="N" Type="Geographic">Australia</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005060" MajorTopicYN="N" Type="Geographic">Europe</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007943" MajorTopicYN="N">Leukemia, Hairy Cell</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008019" MajorTopicYN="Y">Life Style</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009656" MajorTopicYN="N" Type="Geographic">North America</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016273" MajorTopicYN="Y">Occupational Exposure</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4155459</OtherID>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year>
<Month>9</Month>
<Day>1</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2014</Year>
<Month>9</Month>
<Day>1</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2015</Year>
<Month>5</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">25174032</ArticleId>
<ArticleId IdType="pii">lgu004</ArticleId>
<ArticleId IdType="doi">10.1093/jncimonographs/lgu004</ArticleId>
<ArticleId IdType="pmc">PMC4155459</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>France</li>
</country>
</list>
<tree><noCountry><name sortKey="Berndt, Sonja I" sort="Berndt, Sonja I" uniqKey="Berndt S" first="Sonja I" last="Berndt">Sonja I. Berndt</name>
<name sortKey="Cerhan, James R" sort="Cerhan, James R" uniqKey="Cerhan J" first="James R" last="Cerhan">James R. Cerhan</name>
<name sortKey="Clavel, Jacqueline" sort="Clavel, Jacqueline" uniqKey="Clavel J" first="Jacqueline" last="Clavel">Jacqueline Clavel</name>
<name sortKey="Glimelius, Bengt" sort="Glimelius, Bengt" uniqKey="Glimelius B" first="Bengt" last="Glimelius">Bengt Glimelius</name>
<name sortKey="Habermann, Thomas M" sort="Habermann, Thomas M" uniqKey="Habermann T" first="Thomas M" last="Habermann">Thomas M. Habermann</name>
<name sortKey="Hughes, Ann Maree" sort="Hughes, Ann Maree" uniqKey="Hughes A" first="Ann Maree" last="Hughes">Ann Maree Hughes</name>
<name sortKey="Morton, Lindsay M" sort="Morton, Lindsay M" uniqKey="Morton L" first="Lindsay M" last="Morton">Lindsay M. Morton</name>
<name sortKey="Norman, Aaron D" sort="Norman, Aaron D" uniqKey="Norman A" first="Aaron D" last="Norman">Aaron D. Norman</name>
<name sortKey="Sampson, Joshua N" sort="Sampson, Joshua N" uniqKey="Sampson J" first="Joshua N" last="Sampson">Joshua N. Sampson</name>
<name sortKey="Slager, Susan L" sort="Slager, Susan L" uniqKey="Slager S" first="Susan L" last="Slager">Susan L. Slager</name>
<name sortKey="Smith, Alex" sort="Smith, Alex" uniqKey="Smith A" first="Alex" last="Smith">Alex Smith</name>
<name sortKey="Staines, Anthony" sort="Staines, Anthony" uniqKey="Staines A" first="Anthony" last="Staines">Anthony Staines</name>
</noCountry>
<country name="France"><noRegion><name sortKey="Monnereau, Alain" sort="Monnereau, Alain" uniqKey="Monnereau A" first="Alain" last="Monnereau">Alain Monnereau</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Checkpoint

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003401 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 003401 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:25174032
   |texte=   Medical history, lifestyle, and occupational risk factors for hairy cell leukemia: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:25174032" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024

	Serveur d'exploration sur les relations entre la France et l'Australie
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les relations entre la France et l'Australie

Medical history, lifestyle, and occupational risk factors for hairy cell leukemia: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.

Medical history, lifestyle, and occupational risk factors for hairy cell leukemia: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki